FindTrial
Sign In

Inferior alveolar nerve block for patients undergoing mandibular fracture repair for pain releif

A Randomized control study on analgesic efficacy of inferior alveolar nerve block for maxillofacial trauma surgery under general anesthesia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083615
Enrollment
70
Registered
2025-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S026- Fracture of mandible

Interventions

Intervention1: 0.5% isobaric ropivacaine: 0.5% isobaric ropivacaine 2 ml given to block inferior alveolar nerve through oral route Control Intervention1: inferior alveolar nerve block: 2 ml of isobari

Sponsors

Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing mandibular fracture repair under general anesthesia are to be given inferior alveolar nerve block

Exclusion criteria

Exclusion criteria: patients with cardiac problems, hemodynamic instability, allergy to the drug proposed to be administered

Design outcomes

Primary

MeasureTime frame
analgesic efficacy of inferior alveolar nerve block for repair of mandibular fractureTimepoint: analgesic efficacy of inferior alveolar nerve block for repair of mandibular fracture upto 6 hours—

Secondary

MeasureTime frame
rescue analgesic requirement patient satisfaction in postoperative periodTimepoint: 24 hours—

Countries

India

Contacts

Public ContactCHANDRESH JAISAWRA

INSTITUTE OF MEDICAL SCIENCES, BANARAS HINDU UNIVERSITY

atulksingh84@gmail.com8317010317

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026